Information de reference pour ce titreAccession Number: | 00005407-200904080-00027.
|
Author: | O'Connor, Christopher M. MD; Whellan, David J. MD, MHS; Lee, Kerry L. PhD; Keteyian, Steven J. PhD; Cooper, Lawton S. MD, MPH; Ellis, Stephen J. PhD; Leifer, Eric S. PhD; Kraus, William E. MD; Kitzman, Dalane W. MD; Blumenthal, James A. PhD; Rendall, David S. PA-C; Miller, Nancy Houston RN, BSN; Fleg, Jerome L. MD; Schulman, Kevin A. MD; McKelvie, Robert S. MD, PhD; Zannad, Faiez MD, PhD; Pina, Ileana L. MD; for the HF-ACTION Investigators
|
Institution: | Author Affiliations: Duke Clinical Research Institute (Drs O'Connor, Whellan, Lee, Ellis, and Schulman and Mr Rendall) and Departments of Medicine (Drs O'Connor, Kraus, and Schulman), Biostatistics and Bioinformatics (Dr Lee), and Psychiatry and Behavioral Sciences (Dr Blumenthal), Duke University School of Medicine, Durham, North Carolina; Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania (Dr Whellan); Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan (Dr Keteyian); Divisions of Prevention and Population Sciences (Drs Cooper and Leifer) and Cardiovascular Diseases (Dr Fleg), National Heart, Lung, and Blood Institute, Bethesda, Maryland; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Dr Kitzman); Department of Medicine, Stanford University, Stanford, California (Ms Houston Miller); Hamilton Health Sciences, Hamilton, Ontario, Canada (Dr McKelvie); Centre d'Investigation Clinique, Institut National de la Sante et de la Recherche Medicale, Centre Hospitalier Universitaire, Universite Henri Poincare, Nancy, France (Dr Zannad); and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Pina).
|
Title: | |
Source: | JAMA. 301(14):1439&hyhen;1450, April 8, 2009.
|
Abstract: | Context: Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure. Previous studies have not had adequate statistical power to measure the effects of exercise training on clinical outcomes.
Objective: To test the efficacy and safety of exercise training among patients with heart failure.
Design, Setting, and Patients: Multicenter, randomized controlled trial of 2331 medically stable outpatients with heart failure and reduced ejection fraction. Participants in Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) were randomized from April 2003 through February 2007 at 82 centers within the United States, Canada, and France; median follow-up was 30 months.
Interventions: Usual care plus aerobic exercise training, consisting of 36 supervised sessions followed by home-based training, or usual care alone.
Main Outcome Measures: Composite primary end point of all-cause mortality or hospitalization and prespecified secondary end points of all-cause mortality, cardiovascular mortality or cardiovascular hospitalization, and cardiovascular mortality or heart failure hospitalization.
Results: The median age was 59 years, 28% were women, and 37% had New York Heart Association class III or IV symptoms. Heart failure etiology was ischemic in 51%, and median left ventricular ejection fraction was 25%. Exercise adherence decreased from a median of 95 minutes per week during months 4 through 6 of follow-up to 74 minutes per week during months 10 through 12. A total of 759 patients (65%) in the exercise training group died or were hospitalized compared with 796 patients (68%) in the usual care group (hazard ratio [HR], 0.93 [95% confidence interval {CI}, 0.84-1.02]; P = .13). There were nonsignificant reductions in the exercise training group for mortality (189 patients [16%] in the exercise training group vs 198 patients [17%] in the usual care group; HR, 0.96 [95% CI, 0.79-1.17]; P = .70), cardiovascular mortality or cardiovascular hospitalization (632 [55%] in the exercise training group vs 677 [58%] in the usual care group; HR, 0.92 [95% CI, 0.83-1.03]; P = .14), and cardiovascular mortality or heart failure hospitalization (344 [30%] in the exercise training group vs 393 [34%] in the usual care group; HR, 0.87 [95% CI, 0.75-1.00]; P = .06). In prespecified supplementary analyses adjusting for highly prognostic baseline characteristics, the HRs were 0.89 (95% CI, 0.81-0.99; P = .03) for all-cause mortality or hospitalization, 0.91 (95% CI, 0.82-1.01; P = .09) for cardiovascular mortality or cardiovascular hospitalization, and 0.85 (95% CI, 0.74-0.99; P = .03) for cardiovascular mortality or heart failure hospitalization. Other adverse events were similar between the groups.
Conclusions: In the protocol-specified primary analysis, exercise training resulted in nonsignificant reductions in the primary end point of all-cause mortality or hospitalization and in key secondary clinical end points. After adjustment for highly prognostic predictors of the primary end point, exercise training was associated with modest significant reductions for both all-cause mortality or hospitalization and cardiovascular mortality or heart failure hospitalization.
Trial Registration: clinicaltrials.gov Identifier: NCT00047437
JAMA. 2009;301(14):1439-1450 www.jama.com
Copyright 2009 by the American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. American Medical Association, 515 N. State St, Chicago, IL 60610.
|
References: | 1. Hunt SA, Abraham WT, Chin MH, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.
2. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med. 2008;168(4):418-424.
3. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150.
4. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539-1549.
5. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297(12):1319-1331.
6. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999;99(9):1173-1182.
7. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 1992;85(6):2119-2131.
8. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 1995;25(6):1239-1249.
9. McKelvie RS. Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Fail Rev. 2008;13(1):3-11.
10. Piepoli MF, Davos C, Francis DP, Coats AJExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004;328(7433):189.
11. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med. 2004;116(10):693-706.
12. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311(14):874-877.
13. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22(1):23-45.
14. Dickstein K, Cohen-Solal A, Filippatos G, et al. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology; ESC Committee for Practice Guidelines; Document Reviewers. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-2442.
15. Flynn KE, Pina IL, Whellan DJ, et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1451-1459.
16. Whellan DJ, O'Connor CM, Lee KL, et al. HF-ACTION Trial Investigators. Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J. 2007;153(2):201-211.
17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
18. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. 2nd ed. New York, NY: John Wiley & Sons, Inc; 2002.
19. Cox D. Regression models and life-tables (with discussion). J Royal Stat Soc B. 1972;34:187-220.
20. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002;21(19):2917-2930.
21. Lan KK, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70(3):659-663.
22. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549-556.
23. Pfeffer MA, Swedberg K, Granger CB, et al. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall Programme. Lancet. 2003;362(9386):759-766.
24. Cohn JN, Tognoni GValsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345(23):1667-1675.
25. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2(4):755-763.
26. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259(4):539-544.
27. Narang R, Swedberg K, Cleland JG. What is the ideal study design for evaluation of treatment for heart failure? insights from trials assessing the effect of ACE inhibitors on exercise capacity. Eur Heart J. 1996;17(1):120-134.
28. Bensimhon DR, Leifer ES, Ellis SJ, et al. HF-ACTION Trial Investigators. Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol. 2008;102(6):712-717.
|
Language: | English.
|
Document Type: | April 8, 2009: Original Contribution.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0098-7484
|
NLM Journal Code: | 7501160
|
DOI Number: | https://dx.doi.org/10.1001/jama....- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|